# Compass Therapeutics, Inc.: Form 8-K, filed Nov 2, 2022

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2022-11-02
- Accepted by EDGAR: Nov 2, 2022, 21:00 ET
- Period: 2022-11-02
- Accession: 0001171843-22-007012
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000117184322007012/f8k_110222.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000117184322007012/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000117184322007012/f8k_110222.htm

Filed Nov 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001171843-22-007012. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.